Satoru Nagase

发表

The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two‐centered cohort study in Japan

R. Kosaki, Kunihiko Takahashi, J. Ogura, 2022, Congenital anomalies.

Early menopause and a low body mass index are associated with an increased risk of coronary heart disease in Japanese women

T. Ohta, Masafumi Watanabe, Y. Ueno, 2022, Menopause.

Cardiac tamponade during pregnancy due to primary lung cancer: A case report

Masamichi Sato, Masafumi Watanabe, Norikazu Watanabe, 2022, Obstetric Medicine.

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)

M. Shimada, T. Ohta, S. Soeda, 2022, International Journal of Clinical Oncology.

Honeycomb-like Structured Film, a Novel Therapeutic Device, Suppresses Tumor Growth in an In Vivo Ovarian Cancer Model

T. Ohta, H. Nakagawa, Satoru Nagase, 2022, Cancers.

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review

Y. Hirashima, H. Machida, M. Mikami, 2023, Journal of Gynecologic Oncology.

Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan

K. Kawana, K. Matsuo, H. Machida, 2023, Journal of gynecologic oncology.

Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma

T. Ohta, Manabu Seino, H. Yamatani, 2023, International journal of molecular sciences.

Nuclear receptor coactivator‐6 is essential for the morphological change of human uterine stromal cell decidualization via regulating actin fiber reorganization

T. Ohta, J. Kawagoe, A. Sugiyama, 2022, Molecular reproduction and development.